AVENUE THERAPEUTICS, INC. - ATXI
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | History | New | 71,947 | 10 | 0.0% | — | 1 | +71,947 | New | Q1 2024 | May 07, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | History | No change | 52,160 | 7 | 0.0% | 0.0% | 2 | 0 | 0.0% | Q1 2024 | May 13, 2024 |
| VANGUARD GROUP INC | History | No change | 46,293 | 6 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q1 2024 | May 10, 2024 |
| JANE STREET GROUP, LLC | History | New | 29,937 | 4 | 0.0% | — | 5 | +29,937 | New | Q1 2024 | May 16, 2024 |
| STATE STREET CORP | History | No change | 30,593 | 4 | 0.0% | 0.0% | 4 | 0 | 0.0% | Q1 2024 | May 15, 2024 |
| MILLENNIUM MANAGEMENT LLC | History | Reduced | 10,501 | 1 | 0.0% | 0.0% | 6 | -18,104 | -63.29% | Q1 2024 | May 15, 2024 |
| Tower Research Capital LLC (TRC) | History | Added to | 8,872 | 1 | 0.0% | 0.0% | 7 | +2,058 | 30.2% | Q1 2024 | May 15, 2024 |
| CITADEL ADVISORS LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -88,645 | -100.0% | Q1 2024 | May 15, 2024 |
| UBS Group AG | History | Closed out | 0 | 0 | — | — | — | -1,080 | -100.0% | Q1 2024 | May 13, 2024 |
| WELLS FARGO & COMPANY/MN | History | Added to | 4,801 | 0 | — | — | — | +177 | 3.83% | Q1 2024 | May 10, 2024 |
| ROYAL BANK OF CANADA | History | Added to | 554 | 0 | — | — | — | +40 | 7.78% | Q1 2024 | Nov 05, 2024 |
| JPMORGAN CHASE & CO | History | New | 5 | 0 | — | — | — | +5 | New | Q1 2024 | May 10, 2024 |